Davide Fattore

14PUBLICATIONS
62CO-AUTHORS
Medicinal and biomolecular chemistry not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre study.

Vasiliki Nikolaou, Ander Mayor, Vincent Sibaud

|Jan 10, 2026
Perspectives on managing skin manifestations in cancer patients: a multidisciplinary mixed-method survey of oncologists and dermatologists.

Davide Fattore, Omalkhair Abulkhair, Ola M Reda Khorshid

|Oct 30, 2025
Prevention and management of cutaneous immune-related adverse events: EADV Task Force statement.

Davide Fattore, Zoe Apalla, Azael Freites-Martinez

|Oct 16, 2025
Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study.

Damien Giacchero, Vincent Sibaud, Emilie Gerard

|Sep 09, 2025
Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.

Azael Freites-Martinez, Zoe Apalla, Jerry Shapiro

|Feb 03, 2025
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'.

Michela Starace, Luca Rapparini, Stephano Cedirian

Pageof 3